Valneva SE (VALN) Prepaid Assets (2020 - 2026)
Valneva SE (VALN) posted Prepaid Assets of $41.5 million for Q1 2026, up 2.34% sequentially from $40.6 million in Q4 2025, and up 1.57% YoY from $40.9 million in Q1 2025.
Valneva SE (VALN) Prepaid Assets (2020 - 2026) Analysis & Trends
Valneva SE has reported Prepaid Assets for 7 years, with the latest figure at $41.5 million in Q1 2026.
- Quarterly Prepaid Assets rose 1.57% year-over-year to $41.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.5 million (up 1.57% YoY) and the FY2025 annual result came in at $40.6 million, down 10.5% from the prior year.
- Prepaid Assets rose to $41.5 million in Q1 2026 per VALN's latest filing, from $40.6 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $77.4 million in Q1 2022 and troughed at $40.6 million in Q4 2025.
- A 5-year average of $57.9 million and a median of $58.4 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets grew 23.07% in 2023, then tumbled 32.35% in 2025.
- Over 5 years, Prepaid Assets stood at $75.6 million in 2022, then slipped by 27.92% to $54.5 million in 2023, then declined by 17.86% to $44.7 million in 2024, then slipped by 9.35% to $40.6 million in 2025, then climbed by 2.34% to $41.5 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $41.5 million, $40.6 million, and $47.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Valneva SE | 618.67 Mn | 477.41 Mn | 1.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.71 Mn |
| Mar 31, 2026 | 41.51 Mn |
| Dec 31, 2025 | 40.56 Mn |
| Sep 30, 2025 | 47.35 Mn |
| Jun 30, 2025 | 42.51 Mn |
| Mar 31, 2025 | 40.87 Mn |
| Dec 31, 2024 | 44.75 Mn |
| Sep 30, 2024 | 64.89 Mn |
| Jun 30, 2024 | 62.84 Mn |
| Mar 31, 2024 | 58.37 Mn |
| Dec 31, 2023 | 54.48 Mn |
| Sep 30, 2023 | 72.99 Mn |
| Jun 30, 2023 | 70.87 Mn |
| Mar 31, 2023 | 71.58 Mn |
| Dec 31, 2022 | 75.58 Mn |
| Sep 30, 2022 | 59.65 Mn |
| Jun 30, 2022 | 57.58 Mn |
| Mar 31, 2022 | 77.41 Mn |
| Dec 31, 2021 | 81.26 Mn |
| Dec 31, 2020 | 68.95 Mn |